Tenon Medical, Inc. (TNON): Nasdaq/NYSE listing notice — Tenon Medical receives Nasdaq delisting notice for failing minimum stockholders' equity

Tenon Medical, Inc.

Reported stockholders' equity of $1.895M as of March 31, 2026, below Nasdaq's $2.5M minimum.
Must submit a plan to regain compliance by July 6, 2026; Nasdaq may grant up to 180-day extension.
Currently does not meet alternative compliance standards based on market value or net income.
Notice has no immediate effect on trading; company intends to submit compliance plan but no assurance of success.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

May 21, 2026, Tenon Medical, Inc. (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 21, 2026, notifying the Company that it is no longer in compliance with the

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-060662

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.